Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
Angptl2 CRISPR Activation Plasmid (h): sc-406130-ACT
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- Angptl2 CRISPR Activation Plasmid (h) is a synergistic activation mediator (SAM) transcription activation system designed to specifically upregulate gene expression
- Angptl2 CRISPR Activation Plasmid (h) consists of three plasmids at a 1:1:1 mass ratio: a plasmid encoding the deactivated Cas9 (dCas9) nuclease (D10A and N863A) fused to the transactivation domain VP64, and a blasticidin resistance gene; a plasmid encoding the MS2-p65-HSF1 fusion protein, and a hygromycin resistance gene; a plasmid encoding a target-specific 20 nt guide RNA fused to two MS2 RNA aptamers, and a puromycin resistance gene
- The resulting SAM complex binds to a site-specific region approximately 200-250 nt upstream of the transcriptional start site and provides robust recruitment of transcription factors for highly efficient gene activation
- gRNAs encoded by Angptl2 CRISPR Activation Plasmid (h) and Angptl2 CRISPR Activation Plasmid (h2) target distinct regulatory regions upstream of the ANGPTL2 transcriptional start site. One or both designs may be available
- Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: Angptl2 Antibody (H-2): sc-393747
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Angptl2 CRISPR Activation Plasmid (h) | sc-406130-ACT | 20 µg | $397.00 |
ANGPTL2 encodes angiopoietin-like protein 2 (Angptl2), a secreted glycoprotein that modulates cell–cell and cell–matrix interactions in vascular and stromal compartments. Angptl2 is implicated in inflammatory signaling and tissue remodeling, influencing endothelial behavior, leukocyte recruitment, and extracellular matrix dynamics through pathways linked to integrin signaling, NF-κB activation, and cytokine networks. Dysregulated ANGPTL2 expression has been associated with chronic inflammation, metabolic stress responses, fibrosis, and tumor-associated microenvironment changes, making it relevant for studying mechanisms that couple inflammation to angiogenesis and matrix turnover. In vitro, ANGPTL2 perturbation is commonly used to probe paracrine communication between immune cells, fibroblasts, and endothelial cells and to map downstream transcriptional programs.
Angptl2 CRISPR Activation Plasmid (h) provides a targeted, non-destructive approach to upregulating endogenous ANGPTL2 expression without altering the underlying DNA sequence.
Angptl2 CRISPR Activation Plasmid (h) is a three-plasmid synergistic activation mediator (SAM) system engineered for highly efficient, site-specific transcriptional upregulation of the ANGPTL2 locus in human cell lines. The system is built around a catalytically inactive Cas9 (dCas9) carrying two inactivating mutations (D10A and N863A) that eliminate nuclease activity while preserving DNA binding. This dCas9 is fused to VP64, a potent transcriptional activator, and is co-expressed with a blasticidin resistance gene for selection. The second plasmid encodes the MS2-p65-HSF1 fusion protein, a secondary activator complex that works in concert with dCas9-VP64, alongside a hygromycin resistance gene. The third plasmid encodes a target-specific 20 nt sgRNA fused to two MS2 RNA aptamers that recruit the MS2-p65-HSF1 complex to the activation site, accompanied by a puromycin resistance gene. The three plasmids are delivered at a 1:1:1 mass ratio for balanced expression of all system components.
Once assembled at the target locus, the SAM complex binds within approximately 200 bp upstream of the ANGPTL2 transcriptional start site, where VP64, p65, and HSF1 act in concert to recruit transcriptional machinery and drive upregulation of endogenous Angptl2 expression. Unlike nuclease-active Cas9, dCas9 does not introduce double-strand breaks or modify the genomic sequence, preserving the native ANGPTL2 locus and enabling the study of Angptl2-dependent transcriptional responses at the endogenous locus, making it a valuable tool for functional studies, target gene identification, and the modeling of Angptl2 pathway restoration in tumor cells with silenced or reduced ANGPTL2 expression.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.